| 规格: | 98% |
| 分子量: | 710.79 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
Background:
CFT8634 is a degrader targeting BRD9 extracted from patent WO2021178920A1 compound 174. CFT8634 can be used for the research of synovial sarcoma and SMARCB1-deleted solid tumors[1].
[1]. Nasveschuk CG, et, al. Compounds for targeted degradation of brd9. WO2021178920A1.
m.cnreagent.com